Sign up

BMI and JAK Response

Clinical caseRheumatology2 min

An adult patient with rheumatoid arthritis and obesity is considering treatment with a JAK inhibitor. They ask whether BMI is relevant to expected treatment response.

What does the evidence in this abstract support discussing with this patient?